Super-enhancer–associated transcriptional regulatory machinery (SE machinery)

The super-enhancer–associated transcriptional regulatory machinery is a multi-protein complex that assembles at super-enhancers (SEs) to drive the robust expression of genes defining cell identity and disease states. This machinery includes a diverse array of components, such as master transcription factors, the Mediator complex, chromatin readers like BRD4, and transcriptional kinases including CDK7 and CDK9. These proteins often form phase-separated transcriptional condensates that concentrate the transcriptional apparatus at specific genomic loci, facilitating high-level gene activation. In oncology, many tumors exhibit 'transcriptional addiction,' where they rely on the aberrant activity of this machinery to maintain the expression of key oncogenes like MYC. Therapeutic targeting of the machinery, primarily through BET inhibitors and CDK7/9 inhibitors, aims to disrupt these SE-driven programs and induce apoptosis in cancer cells. However, because these components are also involved in basal transcription, drugs targeting them can cause significant systemic toxicities, such as myelosuppression and gastrointestinal distress. Effective clinical application requires the use of biomarkers, such as H3K27ac enrichment or specific SE-driven gene signatures, to identify sensitive patient populations. Ongoing research continues to explore the role of this machinery in other conditions, including inflammatory and neurodegenerative diseases.

Other names

Super-enhancer transcriptional complexSE-driven transcriptional machineryTranscriptional regulatory machinery at super-enhancersSE-associated coactivator complexSE-associated transcriptional machinery

Disruption of the assembly and activity of transcriptional coactivators and kinases at super-enhancer regions, leading to the selective downregulation of oncogenes and cell-identity genes.